Literature DB >> 22614743

The interferon signature and STAT1 expression in rheumatoid arthritis synovial fluid macrophages are induced by tumor necrosis factor α and counter-regulated by the synovial fluid microenvironment.

Rachael A Gordon1, Galina Grigoriev, Angela Lee, George D Kalliolias, Lionel B Ivashkiv.   

Abstract

OBJECTIVE: Type I interferons (IFNs) have emerged as potential activators of the IFN signature and elevated STAT-1 expression in rheumatoid arthritis (RA) synovium, but mechanisms that induce synovial IFN expression are unknown. Recently, tumor necrosis factor α (TNFα) was shown to induce a delayed IFN response in macrophages. We undertook this study to test whether TNFα, classically thought to activate inflammatory NF-κB target genes in RA, also contributes to the "IFN signature" in RA synovial macrophages.
METHODS: Synovial fluid (SF) macrophages purified from 24 patients with RA and 18 patients with spondylarthritides (SpA) were lysed immediately after isolation or were cultured ex vivo in the absence or presence of blockade of endogenous type I IFN or TNFα. Expression of IFN-inducible target genes was measured by quantitative reverse transcription-polymerase chain reaction, and expression of their corresponding proteins was measured by enzyme-linked immunosorbent assay.
RESULTS: Expression of an IFN signature and STAT1 in RA synovial macrophages was suppressed when type I IFNs or TNFα were blocked, whereas TNFα blockade did not affect expression of IFN response genes or STAT1 in SpA synovial macrophages. RA SF suppressed the IFN signature in RA synovial macrophages and in TNFα-, IFNα-, and IFNβ-stimulated control macrophages. Type I IFNs suppressed expression of IL8 and MMP9 in RA synovial macrophages and in TNFα-stimulated control macrophages.
CONCLUSION: Our findings identify a new function of TNFα in RA synovitis by implicating TNFα as a major inducer of the RA synovial IFN response. The results suggest that the expression of IFN response genes in RA synovium is regulated by interplay between TNFα and opposing homeostatic factors expressed in the synovial microenvironment.
Copyright © 2012 by the American College of Rheumatology.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22614743      PMCID: PMC3449023          DOI: 10.1002/art.34544

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  49 in total

1.  Dysregulation of interleukin-10-dependent gene expression in rheumatoid arthritis synovial macrophages.

Authors:  Taras T Antoniv; Lionel B Ivashkiv
Journal:  Arthritis Rheum       Date:  2006-09

2.  Suppression of the effector phase of inflammatory arthritis by double-stranded RNA is mediated by type I IFNs.

Authors:  Anna Yarilina; Edward DiCarlo; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2007-02-15       Impact factor: 5.422

3.  Pharmacological induction of interferon type I activity following treatment with rituximab determines clinical response in rheumatoid arthritis.

Authors:  Saskia Vosslamber; Hennie G Raterman; Tineke C T M van der Pouw Kraan; Marco W J Schreurs; B Mary E von Blomberg; Michael T Nurmohamed; Willem F Lems; Ben A C Dijkmans; Alexandre E Voskuyl; Cornelis L Verweij
Journal:  Ann Rheum Dis       Date:  2011-03-27       Impact factor: 19.103

4.  Toll-like receptor 9-induced type I IFN protects mice from experimental colitis.

Authors:  Kyoko Katakura; Jongdae Lee; Daniel Rachmilewitz; Gloria Li; Lars Eckmann; Eyal Raz
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

5.  Inhibitory effect of TNF alpha antibodies on synovial cell interleukin-1 production in rheumatoid arthritis.

Authors:  F M Brennan; D Chantry; A Jackson; R Maini; M Feldmann
Journal:  Lancet       Date:  1989-07-29       Impact factor: 79.321

6.  A multicentre, randomised, double blind, placebo controlled phase II study of subcutaneous interferon beta-1a in the treatment of patients with active rheumatoid arthritis.

Authors:  J van Holten; K Pavelka; J Vencovsky; H Stahl; B Rozman; M Genovese; A J Kivitz; J Alvaro; G Nuki; D E Furst; G Herrero-Beaumont; I B McInnes; P Musikic; P P Tak
Journal:  Ann Rheum Dis       Date:  2004-07-08       Impact factor: 19.103

Review 7.  Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

Authors:  J E Darnell; I M Kerr; G R Stark
Journal:  Science       Date:  1994-06-03       Impact factor: 47.728

8.  Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis.

Authors:  J Keffer; L Probert; H Cazlaris; S Georgopoulos; E Kaslaris; D Kioussis; G Kollias
Journal:  EMBO J       Date:  1991-12       Impact factor: 11.598

9.  Overview of the biology of type I interferons.

Authors:  George D Kalliolias; Lionel B Ivashkiv
Journal:  Arthritis Res Ther       Date:  2010-04-14       Impact factor: 5.156

10.  Inhibition of interleukin 10 signaling after Fc receptor ligation and during rheumatoid arthritis.

Authors:  Jong-Dae Ji; Ioannis Tassiulas; Kyung-Hyun Park-Min; Ani Aydin; Ingrid Mecklenbrauker; Alexander Tarakhovsky; Luminita Pricop; Jane E Salmon; Lionel B Ivashkiv
Journal:  J Exp Med       Date:  2003-06-02       Impact factor: 14.307

View more
  29 in total

1.  IFN-γ Prevents Adenosine Receptor (A2bR) Upregulation To Sustain the Macrophage Activation Response.

Authors:  Heather B Cohen; Amanda Ward; Kajal Hamidzadeh; Katya Ravid; David M Mosser
Journal:  J Immunol       Date:  2015-09-09       Impact factor: 5.422

2.  HBEGF+ macrophages in rheumatoid arthritis induce fibroblast invasiveness.

Authors:  David Kuo; Jennifer Ding; Ian S Cohn; Fan Zhang; Kevin Wei; Deepak A Rao; Cristina Rozo; Upneet K Sokhi; Sara Shanaj; David J Oliver; Adriana P Echeverria; Edward F DiCarlo; Michael B Brenner; Vivian P Bykerk; Susan M Goodman; Soumya Raychaudhuri; Gunnar Rätsch; Lionel B Ivashkiv; Laura T Donlin
Journal:  Sci Transl Med       Date:  2019-05-08       Impact factor: 17.956

3.  Tumor necrosis factor α induces sustained signaling and a prolonged and unremitting inflammatory response in rheumatoid arthritis synovial fibroblasts.

Authors:  Angela Lee; Yu Qiao; Galina Grigoriev; Janice Chen; Kyung-Hyun Park-Min; Sung Ho Park; Lionel B Ivashkiv; George D Kalliolias
Journal:  Arthritis Rheum       Date:  2013-04

4.  Dual Inhibition of TNFR1 and IFNAR1 in Imiquimod-Induced Psoriasiform Skin Inflammation in Mice.

Authors:  Lynda Grine; Lien Dejager; Claude Libert; Roosmarijn E Vandenbroucke
Journal:  J Immunol       Date:  2015-04-24       Impact factor: 5.422

Review 5.  Regulation of type I interferon responses.

Authors:  Lionel B Ivashkiv; Laura T Donlin
Journal:  Nat Rev Immunol       Date:  2014-01       Impact factor: 53.106

6.  Modulation of TNF-induced macrophage polarization by synovial fibroblasts.

Authors:  Laura T Donlin; Arundathi Jayatilleke; Eugenia G Giannopoulou; George D Kalliolias; Lionel B Ivashkiv
Journal:  J Immunol       Date:  2014-07-23       Impact factor: 5.422

7.  PTPN22 in autoimmunity: different cell and different way.

Authors:  Lionel B Ivashkiv
Journal:  Immunity       Date:  2013-07-25       Impact factor: 31.745

Review 8.  Pathogenic and protective role of macrophages in kidney disease.

Authors:  Qi Cao; Yiping Wang; David C H Harris
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-01

9.  Prolonged tumor necrosis factor α primes fibroblast-like synoviocytes in a gene-specific manner by altering chromatin.

Authors:  Christopher Sohn; Angela Lee; Yu Qiao; Konstantinos Loupasakis; Lionel B Ivashkiv; George D Kalliolias
Journal:  Arthritis Rheumatol       Date:  2015-01       Impact factor: 10.995

10.  Regulation of inflammatory responses in tumor necrosis factor-activated and rheumatoid arthritis synovial macrophages by JAK inhibitors.

Authors:  Anna Yarilina; Kai Xu; Chunhin Chan; Lionel B Ivashkiv
Journal:  Arthritis Rheum       Date:  2012-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.